HGEND

(: HGEND)

Symbol has changed to a new ticker symbol

(HGEN)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side-effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005.

Contact Information

Website: www.humanigen.com
Main Phone: +1 650 243-3100
Address: 533 Airport Boulevard
Address 2: Suite 400
State: CA
City / Town: Burlingame
Country: US
Postal Code: 94005

Issuer Information

Exchange: OTCQB
CEO: Cameron Durrant
Employees: 5
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A